XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Expenses:        
Research and development $ 759,448 $ 101,077 $ 1,226,193 $ 199,744
General and administrative 1,505,432 456,000 2,576,690 928,028
Total operating expenses 2,264,880 557,077 3,802,883 1,127,772
Loss from operations (2,264,880) (557,077) (3,802,883) (1,127,772)
Other Income (Expenses):        
Interest income 13,050 53 23,415 115
Loss on change in fair value of derivative liability (25,431) (63,142)
Interest expense (1,135) (56,290) (2,364) (122,046)
Gain on extinguishment of debt 951,868 951,868
Other income 40,000
Total other income (expenses), net 11,915 870,200 21,051 806,795
Net (loss) income $ (2,252,965) $ 313,123 $ (3,781,832) $ (320,977)
Net (loss) income per common share:        
Basic $ (0.07) $ 0.01 $ (0.11) $ (0.01)
Diluted $ (0.07) $ 0.01 $ (0.11) $ (0.01)
Weighted average number of common stock outstanding:        
Basic 33,180,966 27,536,259 33,394,168 27,247,275
Diluted 33,180,966 30,592,311 33,394,168 27,247,275